TR200103125T2 - Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. - Google Patents

Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.

Info

Publication number
TR200103125T2
TR200103125T2 TR2001/03125T TR200103125T TR200103125T2 TR 200103125 T2 TR200103125 T2 TR 200103125T2 TR 2001/03125 T TR2001/03125 T TR 2001/03125T TR 200103125 T TR200103125 T TR 200103125T TR 200103125 T2 TR200103125 T2 TR 200103125T2
Authority
TR
Turkey
Prior art keywords
anticonvulsant derivatives
autism
improving autism
improving
anticonvulsant
Prior art date
Application number
TR2001/03125T
Other languages
English (en)
Inventor
P. Van Kammen Daniel
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of TR200103125T2 publication Critical patent/TR200103125T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Otizmin tedavisinde kullanima yönelik antikonvülsan türevleri.
TR2001/03125T 1999-02-08 2000-01-18 Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. TR200103125T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11910499P 1999-02-08 1999-02-08

Publications (1)

Publication Number Publication Date
TR200103125T2 true TR200103125T2 (tr) 2002-04-22

Family

ID=22382571

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03125T TR200103125T2 (tr) 1999-02-08 2000-01-18 Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.

Country Status (14)

Country Link
US (1) US6552000B2 (tr)
EP (1) EP1152756B1 (tr)
JP (1) JP2002536328A (tr)
AR (1) AR029334A1 (tr)
AT (1) ATE299371T1 (tr)
AU (1) AU763601B2 (tr)
CA (1) CA2361584C (tr)
DE (1) DE60021252T2 (tr)
DK (1) DK1152756T3 (tr)
ES (1) ES2244411T3 (tr)
MX (1) MXPA01008038A (tr)
PT (1) PT1152756E (tr)
TR (1) TR200103125T2 (tr)
WO (1) WO2000045812A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060020037A1 (en) * 2004-07-22 2006-01-26 Allergan, Inc. Tazarotenic acid and esters thereof for treating autism
US9327069B2 (en) * 2004-12-21 2016-05-03 Boston Scientific Neuromodulation Corporation Methods and systems for treating a medical condition by promoting neural remodeling within the brain
US20070038264A1 (en) * 2004-12-21 2007-02-15 Jaax Kristen N Methods and systems for treating autism
US9095713B2 (en) * 2004-12-21 2015-08-04 Allison M. Foster Methods and systems for treating autism by decreasing neural activity within the brain
US20070034214A1 (en) * 2005-08-12 2007-02-15 Dochniak Michael J Method to affect the development of autism spectrum disorders
US20090076128A1 (en) * 2007-09-15 2009-03-19 Protia Llc Deuterium-enriched topiramate
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
EP3149211A1 (en) * 2014-05-30 2017-04-05 The Children's Hospital of Philadelphia Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism
US11219617B2 (en) 2014-05-30 2022-01-11 The Children's Hospital Of Philadelphia Methods of diagnosing and treating autism
CA3037858A1 (en) 2016-09-21 2018-03-29 JC Pharma, Inc. Method and composition for acute treatment of seizures

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5753693A (en) 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
ATE295176T1 (de) * 1997-05-19 2005-05-15 Repligen Corp Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen

Also Published As

Publication number Publication date
US6552000B2 (en) 2003-04-22
DK1152756T3 (da) 2005-10-10
EP1152756A1 (en) 2001-11-14
DE60021252D1 (de) 2005-08-18
MXPA01008038A (es) 2002-04-24
JP2002536328A (ja) 2002-10-29
AU2615600A (en) 2000-08-25
EP1152756B1 (en) 2005-07-13
DE60021252T2 (de) 2006-05-18
ATE299371T1 (de) 2005-07-15
AU763601B2 (en) 2003-07-31
ES2244411T3 (es) 2005-12-16
CA2361584C (en) 2005-06-14
US20020035068A1 (en) 2002-03-21
WO2000045812A1 (en) 2000-08-10
AR029334A1 (es) 2003-06-25
CA2361584A1 (en) 2000-08-10
PT1152756E (pt) 2005-09-30

Similar Documents

Publication Publication Date Title
TR200102711T2 (tr) Kriz halindeki başağrılarının iyileştirilmesinde kullanıma yönelik antikonvülsan türevler
DE50012408D1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
DE60010098D1 (de) 28-epirapaloge
MXPA03001001A (es) Derivados anticonvulsionantes utiles para el tratameinto de la depresion.
DE69907977D1 (de) Pyrrolobenzodiazepine
DK1187632T3 (da) Behandling med anti-ErbB2-antistoffer
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
PT1147114E (pt) Novos aralquilaminas de espirofuropiridinas uteis em terapia.
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
SE9904377D0 (sv) Pharmaceutical combinations
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
NO20013596L (no) Slambehandling
NO20005548D0 (no) Mykobakterieinhibitorer
TR200103126T2 (tr) Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
ES2187440T3 (es) Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.
DE50009728D1 (de) Mopwaschmittel
UA33933A (uk) Лімфогінний засіб
CY1114651T1 (el) Φαρμακευτικο σκευασμα που περιλαμβανει β-καρβολινη και η χρηση του για τη θεραπεια της σεξουαλικης δυσλειτουργιας